TABLE 2.
Number of Patient Measurements Included in UNOS and Refit Models
| UNOS‐MELD | Patients Capped (%) | Included Patients (%) | ReMELD(‐Na) | Patients Capped (%) | Included Patients (%) | ||
|---|---|---|---|---|---|---|---|
| Creatinine | Lower | 1 | 55.0 | 41.9 | 0.7 | 20.1 | 73 |
| Upper | 4 | 3.1 | 2.5 | 6.9 | |||
| Bilirubin | Lower | 1 | 23.7 | 76.3 | 0.3 | 2.0 | 93.5 |
| Upper | NA | 26.9 | 4.5 | ||||
| INR | Lower | 1 | 9.8 | 91.2 | 0.1 | NA | 94.8 |
| Upper | NA | 2.6 | 5.2 | ||||
| Sodium | Lower | 125 | 2.7 | 72.9 | 120 | 0.7 | 56.3 |
| Upper | 140 | 24.4 | 139 | 43 |
For each parameter the lower and upper bounds are shown. “Patients capped” shows the percentage of the cohort that either lies under or above the chosen bounds. “Patients included” shows the percentage of patients whose measurements are included in the model. The total number of patients included per model is 1,933, 4,815, and 2,748 for the UNOS‐MELD, reMELD, and reMELD‐Na, respectively.